RARE

Ultragenyx Pharmaceutical Inc (RARE) Earnings

Review Ultragenyx Pharmaceutical Inc (RARE) earnings with company data, supporting context and links to related investor research.

Research record updated: . Individual measures may refer to different reporting periods.

Annual EPS
-5.83
Trailing EPS
-5.84
Annual revenue
$673.00M
Trailing revenue
$716.93M
Next earnings date
2026-08-03
Earnings data source
MarketBeat historical revenue consensus + Finnhub earnings

Ultragenyx Pharmaceutical Inc (RARE) Earnings research

The RARE earnings page organizes the available earnings-per-share and revenue context for Ultragenyx Pharmaceutical Inc. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.

Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.